Bristol Myers Squibb is betting big on AI, partnering with Nvidia to build the most powerful AI factory in life sciences—aiming to slash drug discovery time and costs. Facing patent cliffs and generic competition, they’re countering with promising new drugs, a patent-protected cancer treatment, and growing sales. Their stock is undervalued, pays a solid dividend, and their AI play could unlock massive long-term value—even if results take time.
Listen in comfort: Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn.
Advertise on DNN: advertise@thednn.ai
This is an automated, high-level news summary based on public reporting. Report issues to feedback@thednn.ai.
Podden och tillhörande omslagsbild på den här sidan tillhör
The Daily News Now!. Innehållet i podden är skapat av The Daily News Now! och inte av,
eller tillsammans med, Poddtoppen.
